Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-353-0 | CAS number: 6485-55-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro studies:
In an Ames test performed according to OECD Guideline 471 (Bacterial Reverse Mutation Assay) with Salmonella typhimurium TA 1535, TA 1537, TA 98 and TA 100, cis-2,6-dimethylmorpholine (CAS 6485-55-8) concentrations of 20, 100, 500, 2500 and 5000 µg/plate were employed in the presence and absence of Aroclor 1254-induced rat liver S9 mix. At non-toxic test substance concentrations, a significant increase in mutant frequency was not observed (BASF AG, 1995; Val. 2). In a similar AMES test according to OECD Guideline 471 and OECD 472 (Bacterial and E. coli, Reverse Mutation Assay) an isomer mixture of 2,6-dimethylmorpholine (CAS 141-91-3) showed also negative results in the absence and present of Aroclor 1254-induced rat liver S9 mix (BASF AG, 1998; Val. 2).
In two further Ames tests according a standard protocol approved by the National Toxicology Program, 2,6-dimethylmorpholine (CAS 141-91-3) was tested in four Salmonella typhimurium strains (TA98, TAl00, TAl535 and TAl537) in the presence and absence of Aroclor-induced rat or hamster liver S9 (NTP 1980, 1981; Val. 2). In one test a slight increase in revertants was noted in the Salmonella typhimurium strain TA 1535. No noteworthy increase in the number of revertants was observed for all other strains with and without metabolic activation and also in replicate no increase in revertants in the strain TA 1535 was observed.
In an in vitro cytogenetics assay using chinese hamster lung fibroblasts (V79), cis-2,6-dimethylmorpholine (CAS 6485-55-8) was tested both in the absence and presence of metabolic activation (S9 mix), according to the OECD Guideline 473 (BASF AG, 2007; Val.1). The test substance did not cause any biologically relevant increase in the number of structurally aberrant metaphases incl. and excl. gaps at both sampling times either without S9 mix and/or after adding a metabolizing system in two experiments performed independently of each other. The frequency of cells containing numerical chromosome aberrations was strongly increased in the 2nd Experiment after 18 hours exposure at 28 hours-sampling time in the absence of S9 mix. The rate of polyploid cells after treatment with 600 μg/mL (20.05%) clearly exceeded the value of the respective negative control group (3.0%). This observation was corroborated by an increased sample of evaluation of 1000 cells per culture scoring 2 cultures per test group. Cis-2,6-dimethylmorpholine is considered not to have a potent chromosome-damaging (clastogenic) effect under in vitro conditions in V79 cells in the absence and the presence of metabolic activation. However, based on the observation of a strongly increased frequency of polyploid cells after 18 hours treatment and 10 hours recovery in the absence of metabolic activation it has to be considered that the test substance has an aneugenic potential under the experimental conditions described under in vitro conditions in V79 cells.
In a in vitro gene mutation test in CHO cells according to OECD Guideline 476 (HPRT forward mutation assay), cis-2,6-dimethylmorpholine (CAS 6485-55-8) did not cause any increase in the mutant frequencies either without S9 mix or after adding a metabolizing system in two experiments performed independently of each other (BASF AG, 2007; Val. 1)
In vivo studies:
In a micronucleus assay with NMRI mice according to OECD TG 474, 5 male/female animals per group were orally administered single doses of 500, 1000, 2000 mg/kg bw cis-2,6-dimethylmorpholine (CAS 6485-55-8; BASF AG, 2007; Val.1). The single oral administration did not lead to any increase in the number of polychromatic erythrocytes containing either small or large micronuclei. The rate of micronuclei was always within the same range as that of the concurrent negative control in all dose groups and at all sacrifice intervals and within the range of the historical negative control data. An inhibition of erythropoiesis determined from the ratio of polychromatic to normochromatic erythrocytes was detected in the dose of 2000 mg/kg body weight (48-hour sacrifice interval). The test substance did not have any chromosome-damaging (clastogenic) effect, and there were no indications of any impairment of chromosome distribution in the course of mitosis (aneugenic activity) in bone marrow cells in vivo.
Short description of key information:
In vitro studies:
Ames-Test: negative (OECD 471)
Chromosomal Aberration Test: negative (OECD 473)
HPRT-Test: negative (OECD 476)
In vivo studies:
Mouse Micronucleus Test: negative (OECD 474)
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.